hydralazine has been shown to increase minute ventilation , alveolar ventilation , and arterial partial pressure of oxygen ( pao2 ) after short-term administration in patients with chronic obstructive pulmonary disease and pulmonary hypertension .
C0020223
hydralazine
C0020542
pulmonary